Latest Articles
- Keeping up with medical ‘truth’
It’s now documented: by the time you retire, half of what you learned in medical school will be false or obsolete.
Two advances in the management of Parkinson diseaseSecond-generation dopamine agonists may be preferable to levodopa early in the disease. Deep brain stimulation is remarkably effective in refractory cases.
‘White coat hypertension’—should it be treated or not?Treatment is controversial, and any benefit of treatment is unproven.
- Inflammatory bowel disease: Sorting out the treatment options
Options now include aminosalicylates, steroids, azathioprine, 6-mercaptopurine, cyclosporine, methotrexate, infliximab, heparin, and perhaps even antimicrobials and nicotine. How to choose?
- Asymptomatic hyperuricemia: To treat or not to treat
Most people with asymptomatic hyperuricemia do not need further workup or treatment. Who are the exceptions?
- Hyperuricemia and gout: A reign of complacency
We physicians have become complacent about gouty arthritis, developing a false sense of confidence that we actually know how to manage it.
- A 62-year-old man with hypotension and an abnormal chest radiograph
What is the cause of this patient’s symptoms? A self-test.
- GUSTO V: Combination drug treatment of acute myocardial infarction
The combination of abciximab in full doses and reteplase in half doses was not superior to full-dose reteplase alone, but it was “not inferior” either.
